2.71

4.58% -0.13

Aurora Cannabis Inc. (ACB)

Overview News Price History Option Chain Why ACB Down? Discussions Forecast Stock Split

Aurora Cannabis Inc. stock is traded at $2.71, with a volume of 1.58M. It is down -4.58% in the last 24 hours and down -19.82% over the past month. Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Previous Close:

$2.84

Open:

$2.85

24h Volume:

1.58M

Relative Volume:

1.45

Market Cap:

$167.86M

Revenue:

$267.06M

Net Income/Loss:

$-69.17M

P/E Ratio:

-2.397

EPS:

-1.1306

Net Cash Flow:

$-22.38M

1W Performance:

-5.90%

1M Performance:

-19.82%

6M Performance:

-36.08%

1Y Performance:

-40.31%

1-Day Range:

$2.71

$2.86

1-Week Range:

$2.71

$2.975

52-Week Range:

$2.71

$6.665

Aurora Cannabis Inc. Stock (ACB) Company Profile

Name

Aurora Cannabis Inc.

Sector

Healthcare (1100)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

Address

10355 Jasper Avenue, Suite 500, Edmonton, AB

Employee

Twitter

@Aurora_MMJ

Next Earnings Date

2026-08-05

Latest SEC Filings

ACB's Discussions on Twitter

Compare ACB vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACB Aurora Cannabis Inc.	2.71	172.82M	267.06M	-69.17M	-22.38M	-1.1306
TAK Takeda Pharmaceutical Co Adr	16.89	50.65B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.72	41.09B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	35.29	39.45B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.42	30.13B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	547.25	23.00B	3.17B	1.29B	1.01B	27.09

Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-27-26	Initiated	Canaccord Genuity	Buy
Dec-11-24	Initiated	TD Cowen	Buy
Feb-09-24	Upgrade	Canaccord Genuity	Hold → Buy
Sep-21-22	Upgrade	Canaccord Genuity	Sell → Hold
Jun-24-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Jun-06-22	Upgrade	Stifel	Sell → Hold
Sep-28-21	Upgrade	MKM Partners	Sell → Neutral
Sep-03-21	Upgrade	Jefferies	Underperform → Hold
May-14-21	Upgrade	BMO Capital Markets	Underperform → Market Perform
May-14-21	Downgrade	Canaccord Genuity	Hold → Sell
May-11-21	Downgrade	CIBC	Neutral → Sector Underperform
Apr-28-21	Resumed	BofA Securities	Neutral
Feb-12-21	Downgrade	Desjardins	Hold → Sell
Feb-12-21	Downgrade	MKM Partners	Neutral → Sell
Feb-12-21	Downgrade	Needham	Hold → Underperform
Dec-18-20	Downgrade	BMO Capital Markets	Market Perform → Underperform
Nov-16-20	Downgrade	Jefferies	Hold → Underperform
Nov-11-20	Downgrade	Stifel	Hold → Sell
Oct-27-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-21-20	Upgrade	Jefferies	Underperform → Hold
Sep-08-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Jun-24-20	Upgrade	Stifel	Sell → Hold
May-22-20	Downgrade	Jefferies	Hold → Underperform
May-15-20	Upgrade	Piper Sandler	Underweight → Neutral
Feb-27-20	Downgrade	Bryan Garnier	Neutral → Sell
Feb-25-20	Initiated	Needham	Hold
Feb-24-20	Downgrade	Cowen	Outperform → Market Perform
Feb-14-20	Upgrade	MKM Partners	Sell → Neutral
Feb-07-20	Downgrade	Canaccord Genuity	Speculative Buy → Hold
Jan-10-20	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-10-20	Downgrade	Piper Sandler	Overweight → Neutral
Dec-23-19	Downgrade	Jefferies	Buy → Hold
Nov-15-19	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Nov-05-19	Initiated	Cantor Fitzgerald	Neutral
Sep-24-19	Initiated	CIBC	Neutral

View All

Aurora Cannabis Inc. Stock (ACB) Latest News

Jul 02, 2026

Aurora Cannabis (TSX:ACB) Gains on Record Adjusted EBITDA - Kalkine Media

Jul 02, 2026

Jun 30, 2026

Aurora Cannabis Inc. stock falls Tuesday, underperforms market - MarketWatch

Jun 30, 2026

Jun 29, 2026

Aurora Cannabis Inc. stock rises Monday, still underperforms market - MarketWatch

Jun 29, 2026